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Artificial signal transduction across membranes 
Steven Vanuytsel[a], Joanne Carniello[a] and Mark Ian Wallace*[a] 
  
Abstract: A key conundrum in the construction of an artificial cell is to simultaneously 
maintain a robust physical barrier to the external environment, while also providing efficient 
exchange of information across this barrier. Biomimicry provides a number of avenues by 
which such requirements might be met. Here we provide a brief introduction to the 
challenges facing this field and explore progress to date. 
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Introduction 
From an engineering perspective, a cell might be considered an advanced microreactor, 
capable of processing signals from its environment, converting them into complex 
responses. Compared to conventional ‘hard’ devices cells also exhibit unique features that 
would be useful in order to exploit to create new biologically-inspired technologies based on 
artificial cells. Recent advances in synthetic biology have put the ambitious goal of 
constructing an artificial cell within the realms of possibility. Here we focus on a key aspect 
of this grand challenge, the communication of information across cell membranes. 
One difficulty in assessing progress in this area is the diverse and overlapping potential 
applications for such technology. Such outcomes encompass understanding prebiotic life, 
building model systems to dissect the rules governing cell biology, developing new methods 
for biological manufacturing, creating new smart therapeutics, and biological computers.[1–
5] Researchers working towards one goal might have very different constraints on what 
components would be considered appropriate for an artificial cell. Within this broad remit, 
research can also be classified as ‘top-down’ or ‘bottom-up’. Top-down synthetic biology 
seeks to adapt and pare-down existing cellular life to create minimal cells and devices 
optimised for a specific technological outcome. Bottom-up synthetic biology seeks to create 
artificial cells and devices starting from molecular components. In the context of designing 
systems for artificial signal transduction we will focus primarily on bottom-up approaches. 
For an artificial cell to be considered living it must also fulfil a number of basic criteria 
essential to all living things. Although there is still some variation in this classification, we 
would follow Gánti’s chemoton model, and highlight: (1) A unit cell (with a defining 
boundary); (2) Metabolism; (3) Self-maintenance; (4) Information storage; (5) Adaptation to 
its environment.[6,7]  
Fundamentally, to interact with its surroundings a cell must transduce signals into and out 
of the environment. Compartmentalisation is required to separate a cell from its 
surroundings, typically but not exclusively in the form of a lipid membrane. However, this 
compartmentalisation also presents a problem: inherent in its function is the prevention of 
interaction with the surrounding environment - a requirement that is in conflict with the 
need for such a cell to be able to process information, uptake nutrients, and respond 
appropriately to changes in the environment to maximise their survival. 
Biology has already generated solutions to this problem; adopting similar strategies in an 
artificial cell might range from the wholescale incorporation of transmembrane proteins or 
signalling networks, to engineering fully synthetic molecules that seek to replicate the 
strategies that nature has developed. 
Here we seek to provide an overview of the advances in artificial signal transduction across 
membranes as they might be used in the fabrication of an artificial cell, and how they relate 
to or differ from their biological counterparts (Fig. 1) – encompassing (1) ion channels; (2) 
receptors; (3) carriers and pumps; and (4) engaging physical properties of the membrane 
itself to convey signals.  
   
Figure 1. Schematic overview of signal transduction mechanisms: (A) Channels and pores; 
(B) Receptors; (C) Transporters; (D) Membrane binding; (E) Vesicle fusion.  
Ion channels 
Lipid bilayers are essentially impermeable to small inorganic ions due to the hydrophobic 
nature of the bilayer core. To permit exchange of ions across the bilayer, nature has evolved 
specialized ion channels that act to stabilize hydrophilic ions as they cross the membrane, 
and proteins that pierce the membrane to form holes. Ion channels transport ions passively 
down a concentration or electrochemical gradient, with rates of up to 108 ions per 
second.[8,9] Transport is regulated by controlling the opening and closing of channels 
(gating) in response to diverse stimuli, including changes in membrane potential, ligand 
binding, or mechanical force.[10–17] Furthermore, the structural asymmetry observed in 
rectifying ion channels allow a favored direction for the ion flow. Such channels play a key 
role in maintaining the membrane resting potential.[18,19] When constructing an artificial 
ion channel, two obvious requirements must be met: the channel should (1) span the 
membrane; and (2) mediate a passive ion flux. 
Early model ion channels such as gramicidin, alamethicin, and cyclic ion carriers such as 
valinomycin, and the polyene antibiotic amphotericin B,[20–23] have served as longstanding 
inspiration when constructing artificial ion channels. The earliest attempts reported used 
tetra-substituted amphiphilic β-cyclodextrin macrocycles and a membrane-spanning β-
helix.[24,25] Subsequently, a variety of synthetic methods have been applied to create new 
channels; ranging from synthetic macromolecular (in)organic chemistry that uses structural 
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motifs not appearing in nature, to (artificial) peptide and protein engineering, and DNA 
nanotechnology. 
Synthetic ion channels 
Since the 1980s inorganic and organic frameworks provide the mainstay of efforts towards 
the creation of artificial ion channels that are capable of modulating their response to an 
external input. Such constructs have been the subject of significant and recent reviews.[26–
29] In general, these structures exploit host-guest interactions in stacked assemblies of 
synthetic frameworks along a membrane-spanning scaffold to provide a conductive 
pathway for the transport of ions. 
   
Figure 2. Synthetic ion channels. (A) General structure of Gokel’s hydraphiles. Two distal 
crown ethers interact with the aqueous environment, while a third provides a hydrophilic 
element in the middle of the bilayer to facillitate ion transport.[9] (B) A representative 
example of double hydrophilic macrocycles that assemble into ion channels in a lipid 
bilayer.[35] (C) Resorcin[4]arene selectively transports K+ over Na+, and displays voltage-
gating.[40] Images reproduced with permission. 
Anion, cation, and salt co-transport was realized in the 1990s and early 2000s by several 
groups using crown ethers, calix[4]pyrroles, calix- and pillararenes, and steroid derivatives 
such as cholapods, which are tuneable bile acids that display strong Cl- affinities.[30,31] 
Notable examples include the tubular structures of Gokel’s hydraphiles, consisting of three 
crown ethers linked via aliphatic chains[9,32,33] (Fig. 2A), and bolaamphiphile designs by 
Fyles (Fig. 2B), who reported conductances between 10 and 30 picosiemens (pS).[34–36] 
More recently larger, 800 pS conductances were reported for self-assembled crown ether-
based amphiphiles.[37] Crown ethers have also been arranged along other scaffolds, such as 
peptide-based  -helices[38], and β-barrel-forming octiphenyl rigid rods.[39] Macrocycles, 
primarily based on arene- and pyrrole-units, were also implemented in the construction of 
artificial ion channels. For example, a resorcin[4]arene hemi-channel (Fig. 2C) was the first 
to report voltage-dependency, with a conductance of ~6 pS.[40] Another example are the 
ion channels built from the tetrameric macrocycle pyrogallol[4]arene, with conductances 
between 10 and 460 pS[41–43], and the demonstration of chiral-selective transport of 
amino acids through peptide-modified pillar[5 or 6]arenes.[44] Lastly, an artificial hemi-
channel built from a modified cyclodextrin oligosaccharide macrocycle was reported to 
selectively transport anions across lipid bilayers, and could also discriminate between 
halides.[45] More recently, other frameworks such as π-stacked planar architectures and 
metal organic frameworks have emerged, the former using stacked guanosine tetramers to 
transport Na+ across a bilayer.[46] Subsequently, this approach was expanded to folate 
dendrimers[47], stacked macrocycles that assembled into nanotubes with a 5.8 pS 
conductance[48], and rigid-rod π-slides made from oligo-p-phenylene-N,N-
naphthalenediimide that enable transmembrane Cl- transport.[49] Copper-based metal 
organic cuboctahedrons also reportedly permit selective Li+ transport[50], whereas Tecilia 
et al. incorporated rhenium in a tetraporphyrin network to construct a non-selective ion 
channel.[51] Artificial ion channels made from ethylenediamine palladium(II), have been 
proposed to form long-lived toroidal pores with a conductance of 290 pS.[52] Most recently, 
efforts have focused on artificial ion channels responsive to stimuli.[53] For example, 
mimicking of multi-pass transmembrane moieties from oligo(ethylene glycol) chains and 
aromatic units enabled the construction of an artificial mechanosensitive ion channel (Fig. 
3A).[54] 
Peptides and peptidomimetics 
Lipid bilayers are typically 3 to 4 nm thick but reliably synthesizing systems that can span 
such distances is not always straightforward.[26] Arguably the simplest natural structures 
capable of spanning the bilayer come from peptides. In particular, antimicrobial peptides 
exploit a number of pore-forming mechanisms from which inspiration can be drawn.[55] 
Examples are the discrete peptide pores formed by the  -helical transmembrane peptide 
alamethicin[56,57], and the stabilization of toroidal lipid pores by magainin-II.[58,59] Taking 
this strategy to its extreme, “minimalist” channel forming peptides can be synthesised from 
heptads of just two amino acids that self-assemble into  -helical bundles in the 
bilayer.[60,61] These cation-selective channels displayed rectification and channel gating, 
and although no channel conductivity values were reported, the data presented indicates 
maximum values around 150 pS. 
  
Figure 3. Peptide-based channels. (A) Repeating oligo(ethylene glycol) and aromatic 
moieties produce multi-pass transmembrane structures that respond to membrane tension. 
Increasing membrane tension reduced the stacking of the aromatic moieties, reducing ion 
transport.[54] (B) General structure of  -aminoisobutyric acid (Aib) foldamers, which form 
helices in membranes that enable ion transport. Largest conductances were found for 
foldamers consisting of more than 10 Aib units.[65] (C) Rings of cyclic peptides self-assemble 
into peptide nanotubes in a lipid bilayer, creating a passage for ions.[69] (D) Covalent linking 
of cyclic peptides with different internal diameters allow the construction of a venturi-like 
peptide nanotube that allows internal filtering via size-exclusion.[70] Images reproduced 
with permission. 
The same design principle was later extended to include artificial amino acids, which were 
shown to also adopt helical conformations.[62–64] For example, 310-helical foldamers, 
consisting of  -aminoisobutyric acid (Fig. 3B) showed channel activity with a conductance of 
approximately 1500 pS.[65] Alternatively, Yang et al. demonstrated that acyclic small 
molecules featuring two  -aminoxy acids surrounding an isophtalamide scaffold are 
excellent anion receptors[66] and potent Cl- transporters, demonstrating two conductance 
states of 54 and 108 pS.[67]  
β-helical peptide structures are also exploited in antimicrobial agents. Gramicidin A is an 
archetypical example of such a pore forming peptide, where stacked rings of alternating L- 
and D-  -amino acids form a membrane-spanning pore.[20,68] This strategy was used in the 
formation of peptide nanotubes (Fig. 3C&D) from self-assembled stacks of cyclic 
peptides.[69,70] In these structures, the peptide backbone lines the inner hydrophilic core 
of the pore and the hydrophobic side chains face the lipid bilayer core, based on the flat ring 
structures adopted by alternating D- and L-  -amino acid sequences.[71,72] Single-channel 
recordings showed gating behaviour with a conductance of 65 pS. Since then, peptide 
nanotubes have been studied extensively showing, for example, that larger macrocycles 
result in larger channels.[73]  ,ɣ-amino acids improve on these designs by providing control 
over channel properties via functionalization.[74–76] Very recently, stacks of cyclic peptides 
with different internal diameters were covalently linked to produce a venturi-like nanotube 
with an internal filter[77], and peptide nanotubes with large internal diameters that could 
encapsulate C60 fullerene (a “buckyball”) were made by incorporating  ,δ-amino acids.[78] 
Although no encapsulation in a membrane has been reported for these last two structures, 
the authors reported ongoing efforts to achieve this. 
Protein engineering 
Protein engineering encompasses many different techniques to alter the structure of 
existing proteins or to build de novo structures. One key example of this approach in terms 
of artificial ion channels is the creation of chimeric fusions of two transmembrane proteins 
to introduce new functionality. A key example here are the ion-channel-coupled-receptors 
(ICCRs), where G-protein-coupled receptors (GPCRs) are fused to an existing ion 
channel.[79] This strategy originates from biology, where, for example, in ATP-sensitive 
potassium channels (KATP) two subunits are functionally coupled: an inward-rectifying K+ 
channel, Kir6.2 or Kir6.1, and the sulfonylurea receptor (SUR), which serves as a regulator to 
tune Kir6.x gating upon ligand-binding.[80] Moreau et al. replaced SUR with various GPCRs, 
such as the muscarinic M2 receptor and the dopaminergic D2 receptor, to produce a 
chimeric channel responsive to ligand-binding of acetylcholine and dopamine, 
respectively.[81] Subsequently, the same group expanded this approach to successful 
coupling of Kir6.2 to the  2-adrenergic receptor (Fig. 4A)[82], an important drug target 
because of its involvement in smooth muscle relaxation[83], and to opsin, the GPCR that is 
part of the light-sensitive rhodopsin[84], to produce a light-sensitive ion channel.[85] Lastly, 
in 2015, Oh et al. produced an ion channel that responded to odorant simulation by 
coupling Kir6.2 to human olfactory receptors (hORs).[86] 
  
Figure 4. Protein engineering & nanopores. (A) Ion-channel-coupled-receptors fuse G-
protein-coupled receptors to existing ion channels.[82] (B) Fusing alamethicin to a leucine 
zipper creates a metal-gated ion channel. Coordination of iron(III) to the leucine zipper 
segments opens the ion channel, reversed by EDTA.[92] (C) Ligands tethered to 
acetylcholine receptors switch conformation upon irradiation with light, and competition of 
the ligand for acetylcholine binding alters channel gating.[101] (D) Advances in DNA 
nanotechnology allowed the creation of large pores, e.g. mimicking the size of the nuclear 
pore complex (left)[135], and ligand-gated ion channels, where a locking strand can be 
removed via toehold-mediated strand displacement (right).[140] Images reproduced with 
permission. 
An alternative strategy modifies gramicidin A and alamethicin moieties to produce artificial 
ligand-gated ion channels. Woolley et al. reported the construction of a calcium-responsive 
channel by functionalising alamethicin with pyromellitate.[87] Alternatively, streptavidin-
biotin has been used to modify gramicidin and alamethicin channel behaviour upon ligand 
binding.[88–90] Lastly, Futaki and co-workers fused alamethicin to a leucine zipper segment 
from the cFos protein, creating a metal-gated ion channel (Fig. 4B).[91,92] 
Another interesting protein-engineering approach is to functionalize an existing protein 
structure with photoisomerizable chemical moieties to allow conformational switching 
between active and inactive states upon irradiation.[93–97] This was first demonstrated by 
Stankovic et al., who linked two gramicidin A (gA) half-channels together by an azobenzene 
linker.[98] Upon irradiation, the azobenzene reversibly switches conformation forcing the 
two gA half-channels to change from an open to a closed state. Other notable examples 
include modification of MscL from E. Coli to create a light-actuated nanovalve[99], the 
construction of a photo-switchable SecYEG complex[100], and the control over modified 
neuronal acetylcholine receptors by combining them with light-sensitive ligands (Fig. 
4C).[101] 
Nanopores 
Arguably the simplest form of ion channel, pore-forming proteins (or nanopores) create 
large, non-gating, passive channels without intrinsic conformational states.[58] This 
simplicity is an advantage when considering components from which to build an artificial 
cell. Pore-forming proteins are commonly found as bacterial toxins such as  -
hemolysin,[102] aerolysin[103], or anthrax[104,105].  -barrel pores are also found as the 
primary communicating element of the gram-negative bacterial outer membrane.[106,107] 
Beyond their biological role, pore-forming proteins have also been shown to act as excellent 
sensors by measuring the residual ionic flux during the translocation of analytes through the 
pore.[108] This has been applied to achieve nanopore nucleotide sequencing, where the 
nucleobase sequence can be measured from an individual translocating nucleic acid 
polymer.[109,110] 
Nanopores can also be used to introduce connectivity between aqueous compartments in 
networks connected by droplet interface bilayers.[111] Examples are artificial 
batteries[112], and electronic circuits and components.[113,114] Expanding the scope of 
these droplet-networks beyond the oil-phase into the aqueous phase allowed the creation 
of tissue-like material, where pathways can be programmed into by incorporating 
nanopores in specific droplets.[115–117] Incorporating light-activated  -hemolysin 
expression allowed the development of functional artificial neuronal transmission.[118]  
Recently, porins made from single-wall carbon nanotubes have been developed to mimic 
protein nanopores.[119] They were shown to spontaneously insert into lipid bilayers, where 
they display stochastic gating behaviour and a conductance of 70-100 pS.[120] They were 
shown to diffuse in lipid membranes with diffusion coefficients close their natural 
counterparts[121], and can transport water, ions, and uncharged species 
selectively.[122,123] 
DNA nanotechnology 
DNA nanotechnology[124], and specifically DNA origami, has enabled the construction of 
complex 3D nanostructures from which artificial channels and pores might be 
constructed.[125–133] DNA origami uses a long, single “scaffold” strand that is folded into 
the desired shape by binding to many short “staple” strands. Tight control over the 
architecture of complex 3D structures is possible by modifying the staple strands. Using DNA 
origami, nanopores can be created. Early designs[134]  were inspired by  -hemolysin,[102]  
with a transmembrane stem and a barrel-shaped cap that interacts with the lipid 
membrane. To overcome the unfavourable interactions between the negatively-charged 
DNA and the hydrophobic bilayer, 26 cholesterol moieties were attached to the cap. More 
recent designs have created nanopores with larger diameters, which are suited for 
functionalising the pore interior or transferring larger biomolecules (Fig. 4D left).[135,136]  
Pores consisting of DNA can also be formed without relying on the relatively large size of 
DNA origami. For example Burns et al. reported the insertion of DNA nanopores based on 6 
DNA double helices surrounding a 2 nm pore covalently modified with a hydrophobic 
belt.[137,138] Conductances of 395 and 250 pS were reported. Göpfrich et al. also reported 
membrane spanning DNA nanopores, where the pore was lined with 4 duplexes instead of 
6, reducing the pore diameter to 0.8 nm.[139] These pores showed multiple conductance 
states and gating behaviour in single-channel electrophysiology experiments, with a 
maximum conductance of 300 pS. Ligand-gated DNA origami nanopores (Fig. 4D right) have 
also been reported, exploiting a lock and key mechanism[140], where a blocking duplex 
across the channel opens upon binding to two docking sites. Subsequent introduction of a 
complementary “key” strand unzipped the locking strand, opening up the channel pore. 
As an extreme example of a minimal DNA pore, a hydrophobically-functionalized single DNA 
duplex has also been reported to act as a nanopore.[141] Keyser and co-workers decorated 
a single DNA duplex with 6 porphyrin tags to allow incorporation in a lipid bilayer, stabilizing 
a toroidal pore in the membrane. The resulting system had a conductance of 80 pS and 
showed stochastic gating.  
Receptors 
As opposed to ions and small molecules, larger signalling molecules do not physically pass 
through the membrane. Instead, their signals are transferred via interaction with 
membrane-spanning receptors, where structural changes trigger downstream processes. 
Key characteristics of receptor-mediated signal transduction include the receptor’s affinity 
to bind ligands, and the amplification of the signal, either directly or via a mediating 
secondary messenger. Two mechanisms used in nature have inspired researchers to 
produce artificial transmembrane receptors: (1) ligand-induced oligomerisation of receptor 
monomers or stabilization of preformed dimers to activate a catalytic site across the 
membrane, (2) conformational change, where the receptor alters its conformation upon 
ligand binding. 
Receptor oligomerisation 
The archetypal example of receptors that function via oligomerisation are receptor tyrosine 
kinases, which play a crucial role in signal transduction: binding of a ligand to an 
extracellular domain either triggers receptor dimerization, or stabilizes a pre-formed dimer, 
leading to activation of their intracellular kinase domains. The subsequent 
autophosphorylation of tyrosine residues creates binding sites for specific proteins that then 
transmit the information further downstream.[142–147]  
In the early 90s, Kikuchi and Murakami designed cationic steroid cyclophanes which could 
recognise anionic guest molecules when placed in an artificial bilayer membrane, with a 
binding affinity in the high micromolar (µM) range.[148–151] Subsequently in 1998 they 
demonstrated the activation of copper(II)-inactivated lactate dehydrogenase (LDH) by 
coordination of copper(II) to steroid cyclophane receptors that had recognised 1-hydroxy-2-
naphtaldehyde as a signalling molecule.[152] Although occurring completely on one side of 
the membrane, this can be considered as a first artificial bilayer signalling system. This 
approach was later expanded to include receptor dimerization upon ligand binding (Fig. 
5A)[153–155] and photo-switchable receptors.[156] 
  
Figure 5. Artificial receptors. (A) First artificial bilayer signalling system. Recognition of 1-
hydroxy-naphtaldehyde by the steroid cyclophane receptors results in coordination with 
copper(II), which activates the copper(II)-inactivated lactate dehydrogenase (LDH).[153] (B) 
Receptor dimerization due to ligand binding occurs via copper(II) coordination to dansyl 
ethylenediamine receptor moieties.[159] (C) The release of thiopyridine as a secondary 
messenger after diethylenetriamine (DET) induced receptor oligomerisation completes the 
receptor cycle of primary messenger-dimerisation-secondary messenger.[160] (D) G-
protein-coupled receptor-like signal transmission is mimicked via transmembrane  -
aminoisobutyric acid helices. Binding of chiral carboxylate ligands triggers a change in the 
helicity, as reported by pyrene fluorescence.[171-173] (E) Transmembrane signal 
transduction via translocation is achieved via receptor that is too short to span the bilayer. 
An input signal allows the receptor to migrate to the other side of the bilayer, where 
secondary reactions can take place.[176] Images reproduced with permission. 
A second notable design used membrane-spanning compounds with protected thiol 
moieties protruding from the bilayer.[157] Deprotection and oxidation of the external thiols 
resulted in dimerisation of the receptors via the formation of a disulfide bridge, which in 
turn lead to the release of pyridine-2-thiol on the other side of the membrane. Although not 
triggered by a specific primary messenger, this system was the first demonstration of 
artificial transmembrane signal transduction, where an event on one side of the membrane 
triggers a reaction on the other side. Subsequent efforts produced systems responsive to a 
specific primary messenger (Fig. 5B).[158,159] Although the reported system was 
responsive to a primary messenger, with an affinity in the high µM range, the signalling was 
not unidirectional across the membrane. 
Unidirectional artificial transmembrane signalling was reported by Bernitzki and Schrader in 
2009, with an asymmetric transmembrane receptor presenting bisphosphonate dianion 
headgroups on one side of the bilayer, and a fluorescent moiety on the other. Addition of 
diethylenetriamine (DET) induced dimerization of two receptors, which in turn changed the 
fluorescence on the other side of the membrane (Fig. 5C).[160] Secondary messenger 
release following activation is also possible.[161] 
Conformational change 
Another mechanism to transduce signals across a membrane is based on biological 
transmembrane receptors, such as the G-protein-coupled receptor (GPCR) superfamily. 
Binding of a ligand induces a conformational change in the receptor, propagated across the 
membrane, resulting in the activation of a receptor-associated proteins, which transmits the 
signal further downstream.[162–170] 
In a bid to achieve this type of signalling using an artificial receptor, Webb and Clayden 
initially demonstrated that a chiral ligand interacting with an aminoisobutyric acid (Aib) 
helical foldamer, could induce overall changes in the handedness of the helix, thereby 
communicating a signal over several nanometers (Fig. 5D).[171–173] Following up on this 
work, in 2016 this team modified one terminus of the helical foldamer with a photo-
responsive azobenzene motif. Upon insertion into a membrane, they illustrated that the 
light-induced switching of the helical handedness could be propagated across a bilayer.[174] 
A year later, in 2017, the same group modified the artificial receptor with a binding pocket 
to interact with primary messengers.[175] The handedness of the helical receptor depended 
on the chirality of the carboxylic-ligand, which bound tightly to the receptor (Kd < 1 µM), as 
demonstrated by fluorescence of a pair of pyrenes placed on the other terminus, protruding 
from the other side of the membrane. This last system illustrates that de novo designed 
synthetic foldamers can transduce signals by conformational changes, mimicking the 
working principle of GPCRs, although no secondary messengers were included, nor was 
signal amplification established. 
Membrane translocation 
As an alternative to the mechanisms observed in nature, membrane translocation of a 
synthetic transducer has also been reported to achieve transmembrane signalling (Fig. 
5E).[176] Reported by Hunter and Williams, this receptor consists of a membrane-soluble 
steroid core which does not entirely span the bilayer, and two headgroups that can switch 
between a polar and a non-polar state. A protonated morpholine headgroup, which is 
locked in the aqueous phase at low pH, acts as the external sensor. Raising the pH 
deprotonates the morpholine moiety, allowing it to enter the membrane, thereby 
translocating the receptor across the membrane. This movement allows the other 
headgroup, a neutral pyridine-oxime, to protrude into the aqueous phase on the other side 
of the membrane. In the aqueous phase, the pyridine-oxime coordinates with zinc(II), which 
lowers the pKa of the oxime. Subsequent deprotonation activates it as a catalyst for a 
hydrolysis reaction, resulting in the formation of fluorescent product. The translocation 
mechanism was shown to be reversible and a modest five-fold signal amplification was 
reported in a timespan of several hours. Subsequent modifications have incorporated 
response to a primary messenger[177], and the catalytic production of surfactant as a 
secondary messenger, which in turn released calcein from the vesicles, resulting in a fifteen-
fold downstream signal increase.[178] 
Carriers and pumps 
Whereas ion channels make use of a selectivity filter to distinguish cargo, carriers bind their 
solutes and undergo conformational changes when transporting them across the 
membrane. Additionally, the binding sites for the transported molecules are only accessible 
on one side of the membrane. Due to the large diversity in carriers and their substrates, 
transport rates differ substantially. However, as a rule, their transport rates are several 
orders of magnitude lower than for ion channels. Another key parameter of carriers is their 
substrate-specificity, which translates into (generally nanomolar) dissociation constants, 
resembling those of receptors. 
Two main families of transporters can be found in nature: the ATP-binding cassette (ABC) 
superfamily and the solute carrier (SLC) superfamily.[179] ABC transporters are primary 
active transporters, which overturn ATP using highly conserved ABC domains in transporting 
substrates against their concentration gradient into or out of the cell.[180,181] They are 
important players in e.g. antigen processing and exogenous substrate export.[182,183] 
Prokaryotes employ ABC transporters in both the export of noxious substances, and 
nutrient uptake.[184] ABC transporters also play a key role in multidrug resistance in 
bacteria, and in human cancer.[185,186] Most ABC transporter rates are determined via 
ATP hydrolysis assays, making it difficult to assess the number of individual molecules being 
transported over time. However, to illustrate the much lower rate of transport, Zollmann et 
al. have analyzed peptide transport through the peptide ABC transporter TAPL into single 
liposomes and reported a rate of only eight molecules per minute.[187] 
SLCs are primarily used in the selective uptake of small molecules, ranging from (in)organic 
ions and urea, to amino acids.[188–191] Transport can occur either passively, down a 
concentration gradient, or actively if the SLC uses electrochemical gradients to transport its 
substrates against their concentration gradient.[192] 
Pumps transport their substrates against a concentration gradient by harnessing ATP 
hydrolysis or the co-transport of other ions along their electrochemical gradient.[193–195] 
The cardinal example P-type ATPase[194,195] is the Na+/K+-pump, which maintains the cell 
membrane potential by transporting Na+ out of and K+ into the cell. Alternatively, the 
rotary molecular motor F0F1 ATP (synth)ase is the primary source of ATP production in the 
cell, coupling a proton gradient to ATP synthesis, or establishing a proton gradient upon ATP 
consumption.[196,197] 
The systems mentioned in this section were classified as carriers due to an explicit 
conformational change, or movement through the membrane to pick up cargo, thereby 
demonstrating a different mode of action than the artificial ion channels. Like artificial ion 
channels, the field of artificial transporters has long been dominated by organic and 
inorganic supramolecular chemistry. Many excellent reviews are present in the literature 
discussing these extensively[27,32,198–201], so we will only provide a few illustrative 
examples:  in 2002, Smith and colleagues rationally designed crown-based macrobicycle 
carriers capable of co-transporting NaCl or KCl across lipid membranes via diffusion across 
the bilayer.[202] Transport was proposed to occur via an uncomplexed carrier diffusing into 
the vesicle, where it coordinated with the salt, and subsequent diffusing of the carrier-salt 
complex out of the vesicle. Molecular ‘umbrellas’, which attach a central substrate-binding 
scaffold to two amphiphilic components that shield the substrate from the environment, 
have been shown to selectively transport ATP over glutathione across membranes (Fig. 
6A).[203,204] More recently, inspired by biomolecular machinery, a rotaxane molecular 
shuttle was developed that could transport K+ across lipid membranes (Fig. 6B).[205] The 
shuttle is composed of an amphiphilic molecular thread with three binding stations, via 
which a macrocycle tethered to a K+ carrier could translocate from one side of the bilayer to 
the other. This last example illustrates the interest in developing bio-inspired molecular 
machines.[206,207] 
True artificial transmembrane machines should be capable of actively transporting 
substrates against their electrochemical gradient by consuming another type of energy. To 
this extent, two notable examples should be mentioned that realized the build-up of a 
transmembrane proton gradient by using light as an energy source. The first mimicked the 
photoinduced electron transfer that occurs during photosynthesis[208] using a molecular 
‘triad’ consisting of an electron donor and acceptor linked to a photosensitive porphyrin 
group in a membrane to generate a proton gradient. The authors successfully coupled this 
gradient to F0F1 ATP (synth)ase to drive ATP production.[209] A similar result was obtained 
in the second example, when the Matile group demonstrated that p-octiphenyl rods bearing 
fluorescent naphthalene-diimides self-assembled in lipid bilayers to form a π-stacked helical 
structure.[210] In the presence of an electron donor and acceptor system, irradiation of the 
transmembrane structure resulted in long-lived charge separation across the membrane, 
which could be neutralized by quinone-coupled proton transport, resulting in a proton 
gradient. Finally, they showed that they could open up the helix by adding an intercalator, 
resulting in the formation of an ion channel, which quickly dissipated the proton gradient. 
  
Figure 6. Transporters & physical properties of the membrane. (A) Proposed mechanism of a 
molecular umbrella design that selectively transports ATP over glutathione across a lipid 
bilayer. Top left to bottom right: binding of hydrophilic cargo to the umbrella is followed by 
a conformational change in the scaffold to shield the cargo upon bilayer insertion, and 
finally re-opening of the umbrella to release the cargo on the other side of the 
membrane.[203] (B) A rotaxane consisting of an amphiphilic thread and a macrocycle wheel, 
which is tethered to a crown ether, shuttles back and forth through the membrane to 
transport K+ ions.[205] (C) Polymerization of DNA origami curls into long helical structures 
induces and stabilizes lipid tubules in GUVs. The DNA “springs” simultaneously pull at the 
lipid membrane, evoking tubule formation, and hold the latter in place when formed.[225] 
(D) Liposome fusion can be achieved using DNA hybridization, effectively mimicking the 
operation of SNARE proteins.[231] (E) DNA origami nanocages can also trigger vesicle 
fusion. Vesicle-bearing nanocages are brought together by removing the connecting pillars 
via toehold-mediated strand displacement (top). Upon the creation of a lipid tubule, 
complex structures can be enforced by manipulating the geometry of the DNA nanocages 
(bottom).[234] Images reprinted with permission. 
Physical properties of the membrane 
Cells are also capable of the collective reorganization of the membrane itself, both at the 
nano- or micro-scale. Changes in the shape, composition, and phase of lipid membranes is 
mediated by a wide range of important proteins. In turn, changes in these lipid properties 
are sensed by a second cohort of transmembrane and membrane associated proteins. 
Mimicking these processes might be an alternative mechanism for signal transduction. 
Curvature 
Protein association with the membrane can be sufficient to cause significant shape 
changes[211–213], either for example through templating in proteins (such as BAR 
domains[214] or in clathrin-coated pits[215]) or through molecular crowding.[216] Such 
shape changes are sufficient to cause membrane tubulation[217], fission[218], and endo- or 
exocytosis.[219–222] Whereas it is straightforward to understand how endocytosis permits 
information transfer across the membrane, shape changes without cargo transfer are 
harder to envisage as a mechanism of signal transduction. However, biology does exploit 
such mechanisms, as proteins that sculpt membrane curvature can also act as curvature 
sensors.[223]  
Very recently, Schwille and co-workers designed three DNA origami scaffolds with varying 
degrees of curvature to mimic various BAR dimers.[224] They reported binding of the 
scaffolds to model lipid membranes via linkage to a cholesterol moiety, which in turn 
induced membrane deformation and tubulation in giant unilamellar vesicles (GUVs). 
Alternatively, Grome et al. demonstrated that DNA nanosprings – obtained by polymerizing 
curled DNA origami – could also induce membrane tubulation (Fig. 6C).[225] The DNA 
nanosprings are proposed to pull on the lipid as they elongate, and subsequently hold the 
tubule in place. Like the BAR-mimicking DNA scaffolds, it was shown that a higher surface 
coverage and lower membrane tension enhanced tubulation. As opposed to mimicking BAR 
domain proteins, this last design was inspired by dynamins and ESCRT machineries, whose 
helical structure upon polymerization coats lipid tubules.[226,227] Combined, these two 
works illustrate that the field of DNA origami has matured into being able to make 
sophisticated structures that can mimic natural protein assemblies used in membrane 
deformation. 
Vesicle fusion 
Synaptic vesicle fusion[228–230], which employs highly specialized SNARE proteins, has 
been mimicked by using DNA hybridization as the driving force. Anchored complementary 
DNA strands in bilayers of different vesicles have been shown to induced lipid mixing and 
vesicle fusion (Fig. 6D).[231] Fusion efficiency is dependent on linker sequence and 
length.[232] Alternatively, DNA origami rings[233] and nanocages (Fig. 6E)[234] have also 
been used to facilitate fusion of liposomes. 
Demixing 
Taking inspiration from the lipid raft hypothesis, [235] phase changes within the membrane 
can also alter the spatial organisation of membrane components, and hence communicate a 
signal across the membrane. Although not yet realized as components of an artificial cell, 
such processes are well developed; for example, crosslinking of the ganglioside GM1 causes 
lipid demixing in GUVs.[236] DNA origami is one obvious tool with which to alter membrane 
interactions, and have been reviewed recently.[237] Clearly there is the potential for strong 
coupling between factors affecting the physical properties of the membrane, for example 
between lipid demixing and curvature.[238] 
Conclusions 
Drawing inspiration from nature, there is a veritable cornucopia of artificial systems capable 
of transmitting signals across a membrane. Functioning artificial systems have been 
demonstrated that duplicate the function of almost all classes of biological signal 
transduction across the membrane. However, despite these longstanding efforts we 
admittedly still fall far short of the capabilities of the biological systems we seek to mimic. 
Notably, in comparison with biology, the timescales for most of these artificial systems are 
slow, their selectivity is sub-optimal, and they lack the ability to respond to more than one 
type of stimulus, or to amplify a molecular signal. It is unlikely we can outcompete nature in 
terms of catalytic turnover frequency, but we can strive to construct mimics that have a 
comparable degree of selectivity and complexity. 
There is also much to learn from other aspects of synthetic biology, where standardization 
of inputs and outputs from these processes would permit coupling into more complex and 
ambitious artificial function. 
Finally, it is worth noting that here we focus only on one aspect of Gánti’s checklist for 
artificial life; the processes reviewed here must be combined with other key features. 
Especially the coupling to metabolic and/or reproductive systems should be a prime 
objective to enable the construction of more advanced systems. 
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